Probiotic supplement for inflammatory bowel disease
Part of Digestive system clinical trials.
This trial tests whether a probiotic supplement can help manage symptoms of inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. You may be eligible if you are an adult with IBD and can take the supplement for at least 14 days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have been diagnosed with inflammatory bowel disease, including Crohn's disease or ulcerative colitis
- You are receiving treatment or follow-up at a participating hospital
- You are willing to take the probiotic for at least 14 days
- You do not have severe liver, kidney, heart, or lung disease
- You do not have an immune-related disease and have not used biologic immunosuppressive drugs (like anti-TNF agents) in the past 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a daily probiotic supplement (a beneficial bacteria) can improve the protective lining of the gut and reduce leakage in people with inflammatory bowel disease (IBD). It involves taking the supplement for a period of time and undergoing some measurements of gut health.
This trial tests whether adding Probiotic 6600 to your usual treatment can help manage colitis, including ulcerative colitis or Crohn's disease. It aims to see if the probiotic improves symptoms and is safe to use.
This study tests a new food supplement (a synbiotic, which combines good bacteria and food for them) to see if it helps control symptoms of ulcerative colitis, a type of inflammatory bowel disease. If you have mild to moderate ulcerative colitis, this supplement might help reduce inflammation and improve your gut health.
This trial tests a specific probiotic (a type of beneficial bacteria) to see if it can help people with mild to moderate ulcerative colitis by improving the balance of gut microbes. It may be an option if you have not used many advanced treatments before.
This trial tests whether a prebiotic supplement can improve symptoms of ulcerative colitis. It may be a good option for people with active symptoms who are already on stable medications.
This study is testing whether adding a probiotic (Bacillus subtilis) to standard infliximab treatment can improve outcomes for people with active Crohn's disease. It aims to see if the probiotic helps the medication work better.
Hear when a new Crohn Disease and Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.